Advertisement
Screener

INNOVIVA, INC. (INVA) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

INNOVIVA, INC. Increase (Decrease) in Prepaid Expense and Other Assets

INNOVIVA, INC. (INVA) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$203.00 thousand for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-03-17.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2022-03-17

  • INNOVIVA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-12-31 was $895.00K, a 4.99% decline year-over-year.
  • INNOVIVA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-09-30 was -$192.00K, a 462.26% decline year-over-year.
  • INNOVIVA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-06-30 was -$335.00K.
  • INNOVIVA, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-03-31 was -$571.00K.
  • INNOVIVA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2021 was -$203.00K, a 129.94% decline from fiscal 2020.
  • INNOVIVA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2020 was $678.00K, a 500.00% increase from fiscal 2019.
  • INNOVIVA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2019 was $113.00K, a 18.95% increase from fiscal 2018.
  • INNOVIVA, INC. increase (decrease) in prepaid expense and other assets for fiscal 2018 was $95.00K.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2021-12-31$895.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17
$703.00K
derived: sum of 2 quarters · filed 2022-03-17
$368.00K
derived: sum of 3 quarters · filed 2022-03-17
-$203.00K
10-K/A · filed 2022-03-17
2021-09-30-$192.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27
-$527.00K
derived: sum of 2 quarters · filed 2021-10-27
-$1.10M
10-Q · filed 2021-10-27
-$156.00K
derived: sum of 4 quarters · filed 2022-03-17
2021-06-30-$335.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29
-$906.00K
10-Q · filed 2021-07-29
$36.00K
derived: sum of 3 quarters · filed 2022-03-17
$89.00K
derived: sum of 4 quarters · filed 2022-03-17
2021-03-31-$571.00K
10-Q · filed 2021-04-28
$371.00K
derived: sum of 2 quarters · filed 2022-03-17
$424.00K
derived: sum of 3 quarters · filed 2022-03-17
$247.00K
derived: sum of 4 quarters · filed 2022-03-17
2020-12-31$942.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17
$995.00K
derived: sum of 2 quarters · filed 2022-03-17
$818.00K
derived: sum of 3 quarters · filed 2022-03-17
$678.00K
10-K/A · filed 2022-03-17
2020-09-30$53.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27
-$124.00K
derived: sum of 2 quarters · filed 2021-10-27
-$264.00K
10-Q · filed 2021-10-27
$315.00K
derived: sum of 4 quarters · filed 2022-03-17
2020-06-30-$177.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29
-$317.00K
10-Q · filed 2021-07-29
$262.00K
derived: sum of 3 quarters · filed 2022-03-17
$186.00K
derived: sum of 4 quarters · filed 2022-03-17
2020-03-31-$140.00K
10-Q · filed 2021-04-28
$439.00K
derived: sum of 2 quarters · filed 2022-03-17
$363.00K
derived: sum of 3 quarters · filed 2022-03-17
$120.00K
derived: sum of 4 quarters · filed 2022-03-17
2019-12-31$579.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17
$503.00K
derived: sum of 2 quarters · filed 2022-03-17
$260.00K
derived: sum of 3 quarters · filed 2022-03-17
$113.00K
10-K/A · filed 2022-03-17
2019-09-30-$76.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28
-$319.00K
derived: sum of 2 quarters · filed 2020-10-28
-$466.00K
10-Q · filed 2020-10-28
-$130.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$243.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29
-$390.00K
10-Q · filed 2020-07-29
-$54.00K
derived: sum of 3 quarters · filed 2021-02-25
-$117.00K
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31-$147.00K
10-Q · filed 2020-04-29
$189.00K
derived: sum of 2 quarters · filed 2021-02-25
$126.00K
derived: sum of 3 quarters · filed 2021-02-25
-$248.00K
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$336.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$273.00K
derived: sum of 2 quarters · filed 2021-02-25
-$101.00K
derived: sum of 3 quarters · filed 2021-02-25
$95.00K
10-K · filed 2021-02-25
2018-09-30-$63.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30
-$437.00K
derived: sum of 2 quarters · filed 2019-10-30
-$241.00K
10-Q · filed 2019-10-30
$74.00K
derived: sum of 4 quarters · filed 2020-02-19
2018-06-30-$374.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24
-$178.00K
10-Q · filed 2019-07-24
$137.00K
derived: sum of 3 quarters · filed 2020-02-19
-$66.00K
derived: sum of 4 quarters · filed 2020-02-19
2018-03-31$196.00K
10-Q · filed 2019-05-01
$511.00K
derived: sum of 2 quarters · filed 2020-02-19
$308.00K
derived: sum of 3 quarters · filed 2020-02-19
$70.00K
derived: sum of 4 quarters · filed 2020-02-19
2017-12-31$315.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
$112.00K
derived: sum of 2 quarters · filed 2020-02-19
-$126.00K
derived: sum of 3 quarters · filed 2020-02-19
-$12.00K
10-K · filed 2020-02-19
2017-09-30-$203.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31
-$441.00K
derived: sum of 2 quarters · filed 2018-10-31
-$327.00K
10-Q · filed 2018-10-31
-$95.00K
derived: sum of 4 quarters · filed 2019-02-19
2017-06-30-$238.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26
-$124.00K
10-Q · filed 2018-07-26
$108.00K
derived: sum of 3 quarters · filed 2019-02-19
-$96.00K
derived: sum of 4 quarters · filed 2019-02-19
2017-03-31$114.00K
10-Q · filed 2018-05-04
$346.00K
derived: sum of 2 quarters · filed 2019-02-19
$142.00K
derived: sum of 3 quarters · filed 2019-02-19
-$95.00K
derived: sum of 4 quarters · filed 2019-02-19
2016-12-31$232.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19
$28.00K
derived: sum of 2 quarters · filed 2019-02-19
-$209.00K
derived: sum of 3 quarters · filed 2019-02-19
-$48.00K
10-K · filed 2019-02-19
2016-09-30-$204.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
-$441.00K
derived: sum of 2 quarters · filed 2017-11-03
-$280.00K
10-Q · filed 2017-11-03
-$81.00K
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30-$237.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
-$76.00K
10-Q · filed 2017-08-08
$123.00K
derived: sum of 3 quarters · filed 2018-02-23
$41.00K
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31$161.00K
10-Q · filed 2017-05-05
$360.00K
derived: sum of 2 quarters · filed 2018-02-23
$278.00K
derived: sum of 3 quarters · filed 2018-02-23
-$38.00K
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$199.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$117.00K
derived: sum of 2 quarters · filed 2018-02-23
-$199.00K
derived: sum of 3 quarters · filed 2018-02-23
-$320.00K
10-K · filed 2018-02-23
2015-09-30-$82.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$398.00K
derived: sum of 2 quarters · filed 2016-11-03
-$519.00K
10-Q · filed 2016-11-03
-$233.00K
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30-$316.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$437.00K
10-Q · filed 2016-08-04
-$151.00K
derived: sum of 3 quarters · filed 2017-02-28
-$276.00K
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31-$121.00K
10-Q · filed 2016-05-05
$165.00K
derived: sum of 2 quarters · filed 2017-02-28
$40.00K
derived: sum of 3 quarters · filed 2017-02-28
-$1.92M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$286.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$161.00K
derived: sum of 2 quarters · filed 2017-02-28
-$1.79M
derived: sum of 3 quarters · filed 2017-02-28
$338.00K
10-K · filed 2017-02-28
2014-09-30-$125.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
-$2.08M
derived: sum of 2 quarters · filed 2015-11-05
$52.00K
10-Q · filed 2015-11-05
-$19.00K
derived: sum of 4 quarters · filed 2016-02-24
2014-06-30-$1.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$177.00K
10-Q · filed 2015-08-06
$106.00K
derived: sum of 3 quarters · filed 2016-02-24
$498.00K
derived: sum of 4 quarters · filed 2016-02-24
2014-03-31$2.13M
10-Q · filed 2015-05-08
$2.06M
derived: sum of 2 quarters · filed 2016-02-24
$2.45M
derived: sum of 3 quarters · filed 2016-02-24
$872.00K
derived: sum of 4 quarters · filed 2016-02-24
2013-12-31-$71.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
$321.00K
derived: sum of 2 quarters · filed 2016-02-24
-$1.26M
derived: sum of 3 quarters · filed 2016-02-24
-$36.00K
10-K · filed 2016-02-24
2013-09-30$392.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04
-$1.19M
derived: sum of 2 quarters · filed 2014-11-04
$35.00K
10-Q · filed 2014-11-04
$229.00K
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30-$1.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
-$357.00K
10-Q · filed 2014-08-07
-$163.00K
derived: sum of 3 quarters · filed 2015-02-27
$211.00K
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$1.22M
10-Q · filed 2014-05-07
$1.42M
derived: sum of 2 quarters · filed 2015-02-27
$1.79M
derived: sum of 3 quarters · filed 2015-02-27
$1.29M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$194.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$568.00K
derived: sum of 2 quarters · filed 2015-02-27
$66.00K
derived: sum of 3 quarters · filed 2015-02-27
$441.00K
10-K · filed 2015-02-27
2012-09-30$374.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01
-$128.00K
derived: sum of 2 quarters · filed 2013-11-01
$247.00K
10-Q · filed 2013-11-01
-$58.00K
derived: sum of 4 quarters · filed 2014-03-03
2012-06-30-$502.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01
-$127.00K
10-Q · filed 2013-08-01
-$432.00K
derived: sum of 3 quarters · filed 2014-03-03
-$698.00K
derived: sum of 4 quarters · filed 2014-03-03
2012-03-31$375.00K
10-Q · filed 2013-05-01
$70.00K
derived: sum of 2 quarters · filed 2014-03-03
-$196.00K
derived: sum of 3 quarters · filed 2014-03-03
-$1.84M
derived: sum of 4 quarters · filed 2014-03-03
2011-12-31-$305.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03
-$571.00K
derived: sum of 2 quarters · filed 2014-03-03
-$2.21M
derived: sum of 3 quarters · filed 2014-03-03
-$2.29M
10-K · filed 2014-03-03
2011-09-30-$266.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31
-$1.91M
derived: sum of 2 quarters · filed 2012-10-31
-$1.98M
10-Q · filed 2012-10-31
-$908.00K
derived: sum of 4 quarters · filed 2013-02-26
2011-06-30-$1.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01
-$1.72M
10-Q · filed 2012-08-01
-$642.00K
derived: sum of 3 quarters · filed 2013-02-26
-$1.00M
derived: sum of 4 quarters · filed 2013-02-26
2011-03-31-$73.00K
10-Q · filed 2012-05-02
$1.00M
derived: sum of 2 quarters · filed 2013-02-26
$639.00K
derived: sum of 3 quarters · filed 2013-02-26
2010-12-31$1.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
$712.00K
derived: sum of 2 quarters · filed 2013-02-26
-$652.00K
10-K · filed 2013-02-26
-$649.00K
10-K · filed 2012-02-27
2010-09-30-$363.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02
-$1.73M
10-Q · filed 2011-11-02
2010-06-30-$1.36M
10-Q · filed 2011-08-03
2009-12-31-$2.74M
10-K · filed 2012-02-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
OMEROS CORP (OMER)United States$1.456B5.50
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10